Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSPS vs Arginine Dentifrices for Post-Perio Therapy Hypersensitivity
NCT06273930Phase 1Recruiting
- Sponsor
- Armed Forces Institute of Dentistry
- Start
- Feb 2024
- Primary completion
- Oct 2024
- Modality
- Nanoparticles, Device-based Delivery, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of calcium sodium phosphosilicate and arginine in dentin hypersensitivity (DH) (3 arms), sponsored by Armed Forces Institute of Dentistry. Primary endpoints: Visual Analogue Scale for Dentinal Hypersensitivity at 8 weeks and Schiff Cold Air Sensitivity Scale at 8 weeks. Started Feb 2024; status: recruiting.
02
Drugs
calcium sodium phosphosilicatearginine
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT06273930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06273930.